drugset / Trial / NCT00439868

A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure

NCT00439868

Phase 1 Completed 33 enrolled GlaxoSmithKline
Non-randomizedCrossoverDiagnostic

Summary

This study will be conducted in healthy volunteers to investigate the effect on intraocular pressure of 2 weeks of treatment with 300mg WELLBUTRIN XL/day.

Timeline

Start
2007-02-16
Primary completion
2007-06-08
Completion
2007-06-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg Oral

Indications